Núria Valls

Degree in Chemistry, University of Barcelona (1998). PhD and postdoc at the UPC (Politechnical University of Catalunya) in Structural Biology, mainly working with DNA structures. Núria carried out the second postdoc at the IBMB-CSIC (2005-2007) also in structural biology. In this case, she worked with proteins rather than DNA. In brief, during her PhD and postdocs she was working in macromolecule crystallography using synchrotron radiation.

In 2007 she started working in the pharmaceutical company Crystax, dedicated to the development of new drugs for cancer, where she used protein crystallography and synchrotron light for structural studies and development of new drugs. In 2010, Crystax was absorbed by Oryzon Genomics, also a pharmaceutical company, where Núria worked until 2013.

Since 2014 she works in the ALBA Synchrotron Industrial Office, being the contact point between private companies and ALBA techniques. They provide an integral service to the private companies that want to use synchrotron light for their R&D projects.